{"id":"https://openalex.org/W7155533765","doi":"https://doi.org/10.1021/acs.joc.6c00433","title":"Development of Two Complementary Epimerization-Resistant Fragment Coupling Reactions for Highly Convergent Synthesis of N -Alkyl-Rich Peptides","display_name":"Development of Two Complementary Epimerization-Resistant Fragment Coupling Reactions for Highly Convergent Synthesis of N -Alkyl-Rich Peptides","publication_year":2026,"publication_date":"2026-04-24","ids":{"openalex":"https://openalex.org/W7155533765","doi":"https://doi.org/10.1021/acs.joc.6c00433","pmid":"https://pubmed.ncbi.nlm.nih.gov/42030080"},"language":"en","primary_location":{"id":"doi:10.1021/acs.joc.6c00433","doi":"https://doi.org/10.1021/acs.joc.6c00433","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.joc.6c00433","pdf_url":null,"source":{"id":"https://openalex.org/S205050996","display_name":"The Journal of Organic Chemistry","issn_l":"0022-3263","issn":["0022-3263","1520-6904"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Organic Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://chemrxiv.org/doi/pdf/10.26434/chemrxiv-2025-drqlm","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021679829","display_name":"Soji KOMIYA","orcid":"https://orcid.org/0009-0006-0004-0274","observed_orcids":["https://orcid.org/0009-0006-0004-0274"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shio Komiya","raw_affiliation_strings":["Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan"],"raw_orcid":"https://orcid.org/0009-0006-0004-0274","affiliations":[{"raw_affiliation_string":"Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003229709","display_name":"Takumi Matsumoto","orcid":"https://orcid.org/0000-0003-2363-9803","observed_orcids":["https://orcid.org/0000-0003-2363-9803"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takumi Matsumoto","raw_affiliation_strings":["Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066575852","display_name":"Kohei Fujii","orcid":"https://orcid.org/0000-0001-9181-500X","observed_orcids":["https://orcid.org/0000-0001-9181-500X"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kohei Fujii","raw_affiliation_strings":["Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110062283","display_name":"Hiroshi Iwamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Iwamura","raw_affiliation_strings":["Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004558917","display_name":"Kenji Maeda","orcid":"https://orcid.org/0000-0002-9101-9502","observed_orcids":["https://orcid.org/0000-0002-9101-9502"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Maeda","raw_affiliation_strings":["Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan","institution_ids":["https://openalex.org/I4405254473"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021679829"],"corresponding_institution_ids":["https://openalex.org/I4405254473"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":4.4913,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.92303049,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"91","issue":"18","first_page":"6502","last_page":"6516"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13649","display_name":"Advanced Synthetic Organic Chemistry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13326","display_name":"Biochemical and Structural Characterization","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-methylated-peptides","display_name":"N-methylated peptides","score":0.7279999852180481},{"id":"https://openalex.org/keywords/cyclic-peptides","display_name":"cyclic peptides","score":0.9150000214576721},{"id":"https://openalex.org/keywords/convergent-peptide-synthesis","display_name":"convergent peptide synthesis","score":0.9509999752044678}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6855000257492065},{"id":"https://openalex.org/C48424934","wikidata":"https://www.wikidata.org/wiki/Q898912","display_name":"Coupling reaction","level":3,"score":0.597100019454956},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.5291000008583069},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5127999782562256},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4805999994277954},{"id":"https://openalex.org/C2779809887","wikidata":"https://www.wikidata.org/wiki/Q14864278","display_name":"Peptide synthesis","level":3,"score":0.4499000012874603},{"id":"https://openalex.org/C2777289219","wikidata":"https://www.wikidata.org/wiki/Q7632154","display_name":"Substrate (aquarium)","level":2,"score":0.43720000982284546},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4246000051498413},{"id":"https://openalex.org/C175156509","wikidata":"https://www.wikidata.org/wiki/Q1990218","display_name":"Cleavage (geology)","level":3,"score":0.420199990272522},{"id":"https://openalex.org/C203130289","wikidata":"https://www.wikidata.org/wiki/Q926272","display_name":"Epimer","level":2,"score":0.3937999904155731},{"id":"https://openalex.org/C2776235265","wikidata":"https://www.wikidata.org/wiki/Q18392052","display_name":"Fragment (logic)","level":2,"score":0.39320001006126404},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.3677000105381012},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.3449999988079071},{"id":"https://openalex.org/C39409265","wikidata":"https://www.wikidata.org/wiki/Q2687640","display_name":"Convergent synthesis","level":2,"score":0.3165999948978424},{"id":"https://openalex.org/C2776469878","wikidata":"https://www.wikidata.org/wiki/Q2026994","display_name":"Solid-phase synthesis","level":3,"score":0.30630001425743103},{"id":"https://openalex.org/C131584629","wikidata":"https://www.wikidata.org/wiki/Q4308705","display_name":"Coupling (piping)","level":2,"score":0.2892000079154968},{"id":"https://openalex.org/C167625842","wikidata":"https://www.wikidata.org/wiki/Q899763","display_name":"Peptide sequence","level":3,"score":0.27489998936653137},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.26589998602867126},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2606000006198883},{"id":"https://openalex.org/C124790011","wikidata":"https://www.wikidata.org/wiki/Q2069797","display_name":"Peptidomimetic","level":3,"score":0.2533000111579895}],"mesh":[{"descriptor_ui":"D000478","descriptor_name":"Alkylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008745","descriptor_name":"Methylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.joc.6c00433","doi":"https://doi.org/10.1021/acs.joc.6c00433","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.joc.6c00433","pdf_url":null,"source":{"id":"https://openalex.org/S205050996","display_name":"The Journal of Organic Chemistry","issn_l":"0022-3263","issn":["0022-3263","1520-6904"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Organic Chemistry","raw_type":"journal-article"},{"id":"doi:10.26434/chemrxiv-2025-drqlm","doi":"https://doi.org/10.26434/chemrxiv-2025-drqlm","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv-2025-drqlm","pdf_url":"https://chemrxiv.org/doi/pdf/10.26434/chemrxiv-2025-drqlm","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:42030080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42030080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of organic chemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.26434/chemrxiv-2025-drqlm","doi":"https://doi.org/10.26434/chemrxiv-2025-drqlm","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv-2025-drqlm","pdf_url":"https://chemrxiv.org/doi/pdf/10.26434/chemrxiv-2025-drqlm","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7155533765.pdf","grobid_xml":"https://content.openalex.org/works/W7155533765.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W1968715299","https://openalex.org/W1974827600","https://openalex.org/W1977825006","https://openalex.org/W1979639397","https://openalex.org/W1988184759","https://openalex.org/W2013525448","https://openalex.org/W2041463357","https://openalex.org/W2041513075","https://openalex.org/W2043132379","https://openalex.org/W2065889205","https://openalex.org/W2074373576","https://openalex.org/W2129178272","https://openalex.org/W2314301253","https://openalex.org/W2322898236","https://openalex.org/W2495297537","https://openalex.org/W2535651903","https://openalex.org/W2739354616","https://openalex.org/W2752513086","https://openalex.org/W2790484268","https://openalex.org/W2882971792","https://openalex.org/W2951395127","https://openalex.org/W3015613641","https://openalex.org/W3046354178","https://openalex.org/W3090158399","https://openalex.org/W3109868139","https://openalex.org/W3111524336","https://openalex.org/W3121525634","https://openalex.org/W3122225324","https://openalex.org/W3127297964","https://openalex.org/W3172645791","https://openalex.org/W3175075915","https://openalex.org/W3186079597","https://openalex.org/W4200031091","https://openalex.org/W4212959738","https://openalex.org/W4225302943","https://openalex.org/W4226096637","https://openalex.org/W4281771194","https://openalex.org/W4310712976","https://openalex.org/W4366819307","https://openalex.org/W4384662540","https://openalex.org/W4386783981","https://openalex.org/W4387035929","https://openalex.org/W4387909502","https://openalex.org/W4392542388","https://openalex.org/W4395048337","https://openalex.org/W4396804524","https://openalex.org/W4400086184","https://openalex.org/W4403527598","https://openalex.org/W4407925709","https://openalex.org/W4408776805","https://openalex.org/W4411001972","https://openalex.org/W4416109532","https://openalex.org/W7152111437"],"related_works":["https://openalex.org/W7171625953","https://openalex.org/W7152111437","https://openalex.org/W2115891654","https://openalex.org/W1904208869","https://openalex.org/W2116650516","https://openalex.org/W4296033644","https://openalex.org/W4387965490","https://openalex.org/W4396686421","https://openalex.org/W2110787958","https://openalex.org/W2087914530"],"abstract_inverted_index":{"Cyclic":[0],"peptides":[1,44,60],"containing":[2],"N":[3,26,30,58,87,98,131,142,154,174],"-alkylated":[4],"amino":[5,135,158],"acids":[6],"represent":[7,167],"a":[8],"promising":[9],"therapeutic":[10],"modality,":[11],"offering":[12],"access":[13],"to":[14,104],"intracellular":[15],"targets":[16],"previously":[17],"considered":[18],"\u201cundruggable\u201d":[19],"and":[20,50,145,159],"potential":[21],"for":[22],"oral":[23],"administration.":[24],"The":[25,115,137],"-alkyl":[27],"groups":[28],"(e.g.,":[29],"-methyl":[31],"groups)":[32],"play":[33],"an":[34,63,168],"important":[35],"role":[36],"in":[37,170],"enhancing":[38],"the":[39,54,80,127,134,150,171],"pharmacological":[40],"properties":[41],"of":[42,57,66,73,82,86,96,173],"these":[43,163],"by":[45],"improving":[46],"cell":[47],"membrane":[48],"permeability":[49],"metabolic":[51],"stability;":[52],"however,":[53],"efficient":[55],"synthesis":[56,85,172],"-alkyl-rich":[59,88,175],"has":[61,109],"remained":[62],"underdeveloped":[64],"area":[65],"research.":[67],"Herein,":[68],"we":[69],"report":[70],"two":[71,91,164],"types":[72],"peptide":[74],"fragment":[75,94],"coupling":[76,95],"reactions":[77,92,166],"developed":[78],"toward":[79],"realization":[81],"highly":[83],"convergent":[84],"peptides.":[89,176],"These":[90],"enable":[93],"diverse":[97],"-methylated":[99],"substrates":[100],"with":[101,112,130,153],"exceptional":[102],"resistance":[103],"epimer":[105],"formation\u2500a":[106],"challenge":[107],"that":[108],"proven":[110],"difficult":[111],"established":[113],"methods.":[114],"first":[116],"reaction":[117,139],"utilizing":[118,140],"pivaloyl":[119],"mixed":[120],"anhydride":[121],"under":[122],"liquid\u2013liquid":[123],"biphasic":[124],"conditions":[125],"addresses":[126,149],"substrate":[128,151],"combinations":[129,152],"-methylation":[132,155],"at":[133,156],"terminus.":[136],"second":[138],"2-hydroxypyridine":[141],"-oxide":[143],"(HOPO)":[144],"Oxyma":[146],"or":[147],"Oxyma-B":[148],"both":[157],"carboxyl":[160],"termini.":[161],"Together,":[162],"complementary":[165],"advancement":[169]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-04-25T00:00:00"}